The residual risk challenge in CVD: How important are triglycerides?
Video navigation menu
Residual risk challenge in ASCVD 01:13
Causal pathways in ASCVD 03:40
Genetic studies, lipoproteins and ASCVD 07:05
Role of triglyceride-rich lipoproteins 09:06
Summary 12:16
Educational information
This lecture by prof. Ulf Landmesser was part of an accredited symposium "Novel opportunities tackling residual cardiovascular risk: The evolving role of triglycerides" held during the virtual ESC Congress 2020.
Faculty
Prof. Ulf Landmesser, MD, cardiologist, Charité-Universitätsmedizin Berlin, Germany.
Disclosures
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding
Funding for this educational program was provided by an unrestricted educational grant from Amarin.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: